article thumbnail

Despite Safety and Supply Challenges, Outsourcing IV Compounding Remains High

Omnicell

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

article thumbnail

Leading pharmaceutical compounding companies in contract marketing

Pharmaceutical Technology

The information contained within the download document is intended for pharmacists, pharmaceutical executives, sales managers, manufacturers, business development managers, pharmaceutical sales representatives, and any other individual involved in the pharmaceutical compounding sector. . • Packaging. • Lab batch production.